Glaxo Extends Human Genome Offer

June 29, 2012, 9:51 am by Wall Street Journal

GlaxoSmithKline kept up the pressure on Human Genome Sciences by extending its offer for the U.S. biotech company to July 20, four days after the target company's deadline for finding alternative suitors.

Read the full article

More from Wall Street Journal

Electronic Health Data Gaining Favor, HHS Says
Wall Street Journal : May 22, 2013, 12:09 pm
More than half of U.S. doctors have switched to electronic health records and are using them to manage patients' basic medical information and prescriptions.

New Tracking of a Patient's Radiation Exposure
Wall Street Journal : May 21, 2013, 12:01 pm
Some hospital groups are measuring and reporting patients' cumulative medical radiation exposure from tests and scans. How this move may shape treatment and care decisions for patients and their doctors.

Michigan Hospitals Call Off Merger Talks
Wall Street Journal : May 21, 2013, 11:29 am
Beaumont Health System and Henry Ford Health System, two of Michigan's largest hospital systems, called off plans to merge.

Can You Catch Up on Lost Sleep?
Wall Street Journal : May 20, 2013, 9:21 am
Will sleeping more on the weekend make up for lost sno

Actavis to Buy Warner Chilcott
Wall Street Journal : May 20, 2013, 9:10 am
Actavis agreed to acquire Warner Chilcott in a stock swap that values the maker of prescription health-care and dermatology products for women at roughly $5 billion.